AnalystsJason McCarthyJason McCarthy's Stock Forecasts
AnalystsJason McCarthy
Analyst Ranking
Bottom 1%
#4836 out of 4867 analysts
Average Return
-21.64%
Win Rate
26%37 out of 140
Risk vs Reward
Poor
Good
Jason McCarthy's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cassava Sciences IncSAVA | +508.00% | $7.75 | $47.12 | 2020-09-14 - 2021-09-13 | Strong Buy |
Inovio Pharmaceuticals IncINO | +293.89% | $31.44 | $123.84 | 2013-01-31 - 2014-01-31 | Strong Buy |
Capricor Therapeutics IncCAPR | +152.56% | $5.08 | $12.83 | 2024-09-17 - 2025-04-28 | Strong Buy |
Biolife Solutions IncBLFS | +135.87% | $5.91 | $13.94 | 2017-11-10 - 2018-11-09 | Strong Buy |
Achieve Life Sciences IncACHV | +125.00% | $2.16 | $4.86 | 2022-11-16 - 2023-11-15 | Strong Buy |
Jason McCarthy Analyst Color
Get additional color on Jason McCarthy's coverage of popular stocks
Jason McCarthy's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kairos Pharma LtdKAPA | 1 | Strong Buy | $4.00 | +375.06% | Initiates Coverage On | a month ago |
Moleculin Biotech IncMBRX | 3 | Strong Buy | $4.00 | +305.27% | Upgrades | a month ago |
Anixa Biosciences IncANIX | 1 | Strong Buy | $10.00 | +257.14% | Initiates Coverage On | a month ago |
Oncolytics Biotech IncONCY | 2 | Strong Buy | $3.00 | +426.32% | Maintains | 2 months ago |
Abpro Holdings IncABP | 1 | Strong Buy | $4.00 | +1,432.57% | Initiates Coverage On | 2 months ago |
Inmune Bio IncINMB | 1 | Strong Buy | $30.00 | +279.75% | Maintains | 2 months ago |
Kazia Therapeutics LtdKZIA | 2 | Strong Buy | $15.00 | +321.35% | Initiates Coverage On | 3 months ago |
Alterity Therapeutics LtdATHE | 2 | Strong Buy | $12.00 | +244.83% | Maintains | 3 months ago |
Naya Biosciences IncNAYA | 2 | Strong Buy | $24.00 | +990.91% | Upgrades | 3 months ago |
Os Therapies IncOSTX | 2 | Strong Buy | $15.00 | +724.18% | Maintains | 3 months ago |
Reviva Pharmaceuticals Holdings IncRVPH | 4 | Strong Buy | $7.00 | +704.60% | Upgrades | 4 months ago |
Medicus Pharma LtdMDCX | 1 | Strong Buy | $10.00 | +144.50% | Initiates Coverage On | 4 months ago |
Belite Bio IncBLTE | 2 | Strong Buy | $110.00 | +82.78% | Maintains | 5 months ago |
Indaptus Therapeutics IncINDP | 3 | Strong Buy | $5.00 | +941.67% | Maintains | 6 months ago |
Theriva Biologics IncTOVX | 3 | Strong Buy | $6.00 | +325.53% | Maintains | 6 months ago |
Quince Therapeutics IncQNCX | 1 | Strong Buy | $6.00 | +429.57% | Initiates Coverage On | 6 months ago |
Compass Pathways PLCCMPS | 2 | Strong Buy | $12.00 | +209.28% | Maintains | 6 months ago |
Annovis Bio IncANVS | 1 | Strong Buy | $25.00 | +1,512.90% | Upgrades | 6 months ago |
Aim Immunotech IncAIMI | 1 | Strong Buy | $1.00 | +952.63% | Maintains | 6 months ago |
Capricor Therapeutics IncCAPR | 2 | Strong Buy | $25.00 | +94.86% | Maintains | 7 months ago |
Zevra Therapeutics IncZVRA | 2 | Strong Buy | $25.00 | +247.22% | Maintains | 7 months ago |
Mesoblast LtdMESO | 3 | Strong Buy | $12.00 | +5.12% | Upgrades | 7 months ago |
Cns Pharmaceuticals IncCNSP | 1 | Strong Buy | $0.50 | -52.38% | Upgrades | 8 months ago |
Rezolute IncRZLT | 2 | Strong Buy | $10.00 | +165.96% | Maintains | 9 months ago |
Actinium Pharmaceuticals IncATNM | 2 | Strong Buy | $5.00 | +284.62% | Maintains | 9 months ago |
Synaptogenix IncSNPX | 2 | Strong Buy | $14.00 | +473.77% | Upgrades | 10 months ago |
Brainstorm Cell Therapeutics IncBCLI | 1 | Strong Buy | $30.00 | +2,578.57% | Upgrades | 10 months ago |
Dogwood Therapeutics IncDWTX | 1 | Strong Buy | $1.00 | -82.11% | Initiates Coverage On | 10 months ago |
Context Therapeutics IncCNTX | 2 | Strong Buy | $10.00 | +963.83% | Maintains | a year ago |
Metavia IncMTVA | 1 | Strong Buy | $10.00 | +1,164.22% | Initiates Coverage On | a year ago |
Talphera IncTLPH | 1 | Strong Buy | $3.00 | +525.00% | Initiates Coverage On | a year ago |
Lipella Pharmaceuticals IncLIPO | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | a year ago |
Atai Life Sciences NvATAI | 1 | Strong Buy | $6.00 | N/A | Upgrades | a year ago |
Avenue Therapeutics IncATXI | 1 | Strong Buy | $56.25 | N/A | Initiates Coverage On | a year ago |
Neuphoria Therapeutics IncNEUP | 2 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Cyclo Therapeutics IncCYTH | 1 | Strong Buy | $4.00 | N/A | Upgrades | 2 years ago |
Gain Therapeutics IncGANX | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Genelux CorpGNLX | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 2 years ago |
Vistagen Therapeutics IncVTGN | 4 | Strong Buy | $30.00 | N/A | Maintains | 2 years ago |
Galmed Pharmaceuticals LtdGLMD | 3 | Strong Buy | $48.00 | N/A | Upgrades | 2 years ago |
Tuhura Biosciences IncHURA | 2 | Strong Buy | $490.00 | N/A | Upgrades | 2 years ago |
Immutep LtdIMMP | 2 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Tracon Pharmaceuticals IncTCON | 1 | Strong Buy | $60.00 | N/A | Maintains | 2 years ago |
Plus Therapeutics IncPSTV | 2 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Vertex Pharmaceuticals IncVRTX | 3 | Strong Buy | $400.00 | N/A | Maintains | 2 years ago |
Contrafect CorpCFRXQ | 2 | Strong Buy | $3.00 | N/A | Upgrades | 2 years ago |
Panbela Therapeutics IncPBLA | 3 | Strong Buy | $900.00 | N/A | Upgrades | 2 years ago |
Aprea Therapeutics IncAPRE | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 2 years ago |
Unicycive Therapeutics IncUNCY | 2 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
Nls Pharmaceutics LtdNLSP | 3 | Strong Buy | $160.00 | N/A | Upgrades | 2 years ago |
Onconetix IncONCO | 1 | Strong Buy | $4.00 | N/A | Initiates Coverage On | 2 years ago |
Achieve Life Sciences IncACHV | 1 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Abvc Biopharma IncABVC | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Inovio Pharmaceuticals IncINO | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Gilead Sciences IncGILD | 2 | Strong Buy | $92.00 | N/A | Maintains | 2 years ago |
Eterna Therapeutics IncERNA | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Volitionrx LtdVNRX | 1 | Strong Buy | $5.00 | N/A | Maintains | 3 years ago |
Adial Pharmaceuticals IncADIL | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Aridis Pharmaceuticals IncARDS | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
9 Meters Biopharma IncNMTRQ | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Femasys IncFEMY | 1 | Strong Buy | $5.00 | N/A | Initiates Coverage On | 3 years ago |
Geovax Labs IncGOVX | 2 | Strong Buy | $90.00 | N/A | Reiterates | 3 years ago |
Kiora Pharmaceuticals IncKPRX | 1 | Strong Buy | $900.00 | N/A | Initiates Coverage On | 3 years ago |
Acurx Pharmaceuticals IncACXP | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 3 years ago |
Protagenic Therapeutics IncPTIX | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 4 years ago |
Renovorx IncRNXT | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 4 years ago |
Omeros CorpOMER | 4 | Hold | N/A | N/A | Downgrades | 4 years ago |
Stealth Biotherapeutics CorpMITO | 1 | Strong Buy | $3.00 | N/A | Initiates Coverage On | 4 years ago |
Enveric Biosciences IncENVB | 1 | Strong Buy | $4,500.00 | N/A | Initiates Coverage On | 4 years ago |
Mind Medicine IncMNMD | 1 | Strong Buy | $90.00 | N/A | Initiates Coverage On | 4 years ago |
Clene IncCLNN | 1 | Strong Buy | $360.00 | N/A | Initiates Coverage On | 4 years ago |
Cohbar IncCWBR | 1 | Strong Buy | $90.00 | N/A | Initiates Coverage On | 4 years ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $7.00 | N/A | Upgrades | 4 years ago |
Fennec Pharmaceuticals IncFENC | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 4 years ago |
Co Diagnostics IncCODX | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Medicinova IncMNOV | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 4 years ago |
Cassava Sciences IncSAVA | 2 | Strong Buy | $80.00 | N/A | Maintains | 4 years ago |
Galapagos NvGLPG | 1 | Strong Buy | $170.00 | N/A | Initiates Coverage On | 4 years ago |
Karuna Therapeutics IncKRTX | 1 | Strong Buy | $150.00 | N/A | Initiates Coverage On | 4 years ago |
Monopar TherapeuticsMNPR | 1 | Strong Buy | $55.00 | N/A | Initiates Coverage On | 5 years ago |
Tff Pharmaceuticals IncTFFP | 1 | Strong Buy | $300.00 | N/A | Initiates Coverage On | 5 years ago |
Diamedica Therapeutics IncDMAC | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 5 years ago |
Cellectar Biosciences IncCLRB | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 5 years ago |
Dmk Pharmaceuticals CorpDMKPQ | 3 | Strong Buy | $105.00 | N/A | Upgrades | 5 years ago |
Aptose Biosciences IncAPTOF | 1 | Strong Buy | $7,200.00 | N/A | Initiates Coverage On | 5 years ago |
Artelo Biosciences IncARTL | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | 6 years ago |
Bluebird Bio IncBLUE | 6 | Strong Buy | $3,200.00 | N/A | Upgrades | 6 years ago |
Matinas Biopharma Holdings IncMTNB | 3 | Strong Buy | $250.00 | N/A | Maintains | 6 years ago |
Scynexis IncSCYX | 2 | Strong Buy | $40.00 | N/A | Maintains | 7 years ago |
Adma Biologics IncADMA | 1 | Strong Buy | $12.00 | N/A | Maintains | 7 years ago |
Sellas Life Sciences Group IncSLS | 1 | Strong Buy | $250.00 | N/A | Maintains | 7 years ago |
Beyondspring IncBYSI | 1 | Strong Buy | $48.00 | N/A | Maintains | 7 years ago |
Viking Therapeutics IncVKTX | 1 | Strong Buy | $14.00 | N/A | Maintains | 7 years ago |
Biolife Solutions IncBLFS | 2 | Strong Buy | $12.00 | N/A | Maintains | 7 years ago |
Atossa Therapeutics IncATOS | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 7 years ago |
Juno Therapeutics IncJUNO | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Imunon IncIMNN | 1 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.